CBX2 and diffuse large B-cell lymphoma: In our study, Kaplan–Meier survival analysis showed that the high mRNA expressions of CBX2/3/5/6 were associated with poor prognosis of DLBCL patients, whereas high expression of CBX1 was correlated with better prognosis of patients.